Page last updated: 2024-12-05

tert-butylacrylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tert-Butylacrylamide is a versatile monomer used in the synthesis of various polymers and copolymers. It is known for its ability to impart unique properties to materials, such as increased hydrophobicity, improved mechanical strength, and enhanced biocompatibility. The synthesis of tert-butylacrylamide typically involves the reaction of tert-butylamine with acrylic acid or acryloyl chloride. Its effects can vary depending on the application, but it is often used to modify the properties of polymers, such as enhancing their water resistance or improving their adhesion to surfaces. tert-Butylacrylamide is studied due to its potential applications in fields like medicine, pharmaceuticals, and materials science. For example, it has been investigated for its use in drug delivery systems, tissue engineering, and the development of new biocompatible materials. The research interest in tert-butylacrylamide stems from its unique chemical structure, which allows for versatile modifications and the creation of materials with tailored properties.'
```

tert-butylacrylamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7877
CHEMBL ID3184503
SCHEMBL ID26705
MeSH IDM0296933

Synonyms (48)

Synonym
nsc 5287
ai3-25002
brn 1742331
einecs 203-505-6
n-(1,1-dimethylethyl)-2-propenamide
tert-butylacrylamide
acrylamide, n-tert-butyl-
n-tert-butylacrylamide
2-propenamide,1-dimethylethyl)-
nsc5287
nsc-5287
107-58-4
2-propenamide, n-(1,1-dimethylethyl)-
inchi=1/c7h13no/c1-5-6(9)8-7(2,3)4/h5h,1h2,2-4h3,(h,8,9
n-tert-butylacrylamide, 97%
n-(tert-butyl)acrylamide
n-tert-butylprop-2-enamide
B0703
NCGC00248285-01
4-04-00-00664 (beilstein handbook reference)
t-bu acrylamide
ec 203-505-6
xj13fsh48k ,
unii-xj13fsh48k
EN300-64881
tox21_301092
NCGC00254992-01
dtxsid1040114 ,
cas-107-58-4
dtxcid9020114
AKOS005174133
FT-0675966
SCHEMBL26705
n-tert-butyl-2-propenamide
n-t-butyl-2-propenamide
n-tert.-butylacrylamide
n-t-butyl acrylamide
n-t-butylacrylamide
CHEMBL3184503
mfcd00026271
n-tert-butyl acrylamide
AS-17781
AMY40862
n- tertiary butylacrylamide
D70371
Q27293858
CS-W013480
Z440633548

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In this study, we investigate nanogel suspensions in order to improve the topical ocular therapy by reducing dosage and frequency of administration."( Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.
Hoare, T; Jamard, M; Sheardown, H, 2016
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency21.87240.000817.505159.3239AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.64480.000229.305416,493.5996AID743075
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency51.43500.000323.4451159.6830AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (8.33)18.2507
2000's7 (29.17)29.6817
2010's14 (58.33)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.00 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index38.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]